Avantor Inc (AVTR)
20.59
+0.23
(+1.13%)
USD |
NYSE |
Nov 22, 10:58
Avantor Gross Profit Margin (Quarterly): 32.92% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 32.92% |
June 30, 2024 | 34.15% |
March 31, 2024 | 33.96% |
December 31, 2023 | 33.11% |
September 30, 2023 | 33.64% |
June 30, 2023 | 33.83% |
March 31, 2023 | 35.10% |
December 31, 2022 | 34.23% |
September 30, 2022 | 35.05% |
June 30, 2022 | 33.90% |
March 31, 2022 | 35.37% |
December 31, 2021 | 33.94% |
September 30, 2021 | 33.58% |
June 30, 2021 | 33.71% |
Date | Value |
---|---|
March 31, 2021 | 34.32% |
December 31, 2020 | 32.48% |
September 30, 2020 | 31.55% |
June 30, 2020 | 33.18% |
March 31, 2020 | 33.04% |
December 31, 2019 | 31.52% |
September 30, 2019 | 31.52% |
June 30, 2019 | 32.05% |
March 31, 2019 | 32.11% |
December 31, 2018 | 29.36% |
September 30, 2018 | 32.04% |
June 30, 2018 | 31.67% |
March 31, 2018 | 31.04% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
31.52%
Minimum
Dec 2019
35.37%
Maximum
Mar 2022
33.63%
Average
33.77%
Median
Gross Profit Margin (Quarterly) Benchmarks
Bruker Corp | 48.45% |
Azenta Inc | 40.82% |
Harvard Bioscience Inc | 58.10% |
Bionano Genomics Inc | -139.1% |
Akoya Biosciences Inc | 62.32% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 5.80% |
Return on Assets | 2.42% |
Return on Invested Capital | 2.91% |
Profit Margin (Quarterly) | 3.37% |
Operating Margin (Quarterly) | 7.27% |
Return on Net Operating Assets | 2.58% |